Home/Investors/Euclidean Capital

Euclidean Capital

Biotech Investor · 3 portfolio companies

Portfolio
3
Focus Areas
4
Top Stage
platform

Portfolio Companies

CompanyValuation
Octant Bio
Ribon Therapeutics
Ratio Therapeutics